SleepPub Date : 2026-11-10DOI: 10.1093/sleep/zsag221
Hannah Scott, Bastien Lechat, Kelly Sansom, Tracey L Sletten, Robert Adams, Andrew J K Phillips
{"title":"The case for considering irregular sleep as a clinical sleep disorder.","authors":"Hannah Scott, Bastien Lechat, Kelly Sansom, Tracey L Sletten, Robert Adams, Andrew J K Phillips","doi":"10.1093/sleep/zsag221","DOIUrl":"10.1093/sleep/zsag221","url":null,"abstract":"","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148797450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-11-10DOI: 10.1093/sleep/zsag217
Curtis Tilves, Calliope Holingue, Sarah K Wanigatunga, Chee W Chia, Ni Zhao, Mark N Wu, Jennifer A Schrack, Eleanor M Simonsick, Luigi Ferrucci, Toshiko Tanaka, Adam P Spira, Noel T Mueller
{"title":"Associations of self-reported and actigraphic sleep with gut microbiome composition and diversity among older adults.","authors":"Curtis Tilves, Calliope Holingue, Sarah K Wanigatunga, Chee W Chia, Ni Zhao, Mark N Wu, Jennifer A Schrack, Eleanor M Simonsick, Luigi Ferrucci, Toshiko Tanaka, Adam P Spira, Noel T Mueller","doi":"10.1093/sleep/zsag217","DOIUrl":"10.1093/sleep/zsag217","url":null,"abstract":"<p><strong>Study objectives: </strong>Poor sleep is linked to adverse health outcomes. Animal studies suggest the gut microbiome may influence sleep, but human findings remain inconsistent. We examined associations of self-reported insomnia symptoms, daytime sleepiness, and actigraphy-measured sleep with gut microbiome diversity and composition in older adults.</p><p><strong>Materials and methods: </strong>We studied 869 Baltimore Longitudinal Study of Aging participants with self-reported sleep and shotgun metagenomic sequencing; 332 also had actigraphy. We tested associations of sleep with alpha diversity, beta diversity, and species composition using regression, PERMANOVA, and ANCOM-BC2, adjusting for age, sex, BMI, physical activity, education, and depressive symptoms.</p><p><strong>Results: </strong>Participants had a mean age of 70.7 years; 54.8 per cent were female and 66.9 per cent white. Trouble falling asleep ≥5 times/week was associated with higher Shannon diversity (β = 0.41 SD; 95% CI: 0.09, 0.73) and Pielou's evenness, but not richness metrics. No actigraphy-measured sleep variables were associated with alpha or beta diversity. Beta diversity analyses suggested excessive sleepiness (1-2 or 3-4 times/week) was associated with a different microbial composition, though the variance explained was small. In species-level analyses, frequent insomnia symptoms or excessive sleepiness were associated with depleted or undetected Eubacterium sp. CAG:251. In exploratory actigraphy models, each doubling of sleep efficiency was associated with higher Eubacterium sp. CAG:251 prevalence (PR = 2.15; 95% CI: 1.47, 3.14), while each 30-minute increase in wake after sleep onset was associated with lower prevalence (PR = 0.49; 95% CI: 0.29, 0.81).</p><p><strong>Conclusions: </strong>Global diversity findings were limited and inconsistent, whereas subjective and objective sleep disturbances converged on Eubacterium sp. CAG:251. These findings are exploratory and require longitudinal replication.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13747337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148697786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-11-10DOI: 10.1093/sleep/zsag199
Kirsten L Spaargaren, Sander Begeer, Smiddy Nieuwenhuis, Jessie Bradley, Heleen Riper, Kirstin Greaves-Lord, Annemieke van Straten
{"title":"Effectiveness of guided internet-delivered cognitive behavioral therapy for insomnia in autistic adults (i-Sleep Autism): a randomized controlled trial.","authors":"Kirsten L Spaargaren, Sander Begeer, Smiddy Nieuwenhuis, Jessie Bradley, Heleen Riper, Kirstin Greaves-Lord, Annemieke van Straten","doi":"10.1093/sleep/zsag199","DOIUrl":"10.1093/sleep/zsag199","url":null,"abstract":"<p><p>An estimated 60% of autistic adults suffer from insomnia symptoms, which significantly impairs daily functioning and wellbeing. This study evaluated the effectiveness of i-Sleep Autism, a 5-week, guided self-help internet-delivered cognitive behavioral therapy-based intervention (ICBT-I) for insomnia in autistic adults. In co-creation with seven autistic adults with sleeping problems, i-Sleep Autism was adapted from i-Sleep, a pre-existing non-autism specific intervention. A total of 163 adults with autism and insomnia (ISI ≥ 10) was randomly allocated to i-Sleep Autism (n = 82) or waitlist control (n = 81; receiving psychoeducation and sleep hygiene). Participants were assessed at baseline (T0), mid-intervention (T1; 3-weeks), post-test (T2; 6-weeks), and follow-up (T3; 6 months) on insomnia severity (primary outcome), pre-sleep arousal, anxiety, depression, daily functioning, and quality of life. In the intervention group, 56.1% completed four, and 50% all five modules. Intent-To-Treat analyses revealed a significant reduction in insomnia severity at T1 and T2 (d = 1.02, 95%CI = [0.65, 1.40]), and cognitive- and somatic pre-sleep arousal at post-test, when comparing intervention to control. The intervention group showed significantly higher quality of life at post-test. At T2, 37.8% of the intervention group versus 11.1% of the control group showed clinically meaningful improvement of insomnia. Effects on insomnia severity were maintained at 6-month follow up. No significant effects were found for anxiety, depression, or daily functioning. This is the first RCT to investigate autism-adapted ICBT-I for autistic adults suffering from insomnia. i-Sleep Autism effectively and sustainably improves insomnia. Additional strategies are needed to support dropouts and those who did not benefit. Statement of Significance Insomnia is very common among autistic adults and has substantial consequences for daily functioning and well-being, yet evidence-based sleep interventions for this group are lacking. This study provides the first randomized controlled evaluation of an internet-delivered cognitive behavioral intervention for insomnia that was adapted in collaboration with autistic adults. The findings demonstrate that autism-adapted, guided, digital sleep interventions can meaningfully improve sleep and related outcomes in autistic adults, with effects that are sustained over time. At the same time, considerable variation in engagement and response highlights the need for further refinement and personalization. Future research should focus on identifying who benefits most, optimizing support for non-responders, and improving accessibility and adherence.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13747339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148520931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-11-10DOI: 10.1093/sleep/zsag189
Savit R Malhotra, Quynh Theresa Do, Stacey Gunn, Sahil Chopra, Kirstin Knobbe Lloyd, Robert J Thomas
{"title":"Beyond device downloads: residual sleep apnea and hypoxemia missed by flow-based CPAP monitoring.","authors":"Savit R Malhotra, Quynh Theresa Do, Stacey Gunn, Sahil Chopra, Kirstin Knobbe Lloyd, Robert J Thomas","doi":"10.1093/sleep/zsag189","DOIUrl":"10.1093/sleep/zsag189","url":null,"abstract":"<p><strong>Study objectives: </strong>Positive Airway Pressure (PAP) therapy download reports are the current objective data standard for assessing sleep apnea treatment success, providing information on usage, leak, and residual apnea-hypopnea index (AHI). However, follow-up parallel testing can offer added value in measuring sleep and respiratory health in patients receiving PAP therapy. This study compares residual PAP-derived AHI (AHIFLOW) with cardiopulmonary coupling (CPC)-derived AHI3% (AHICPC). We specifically examined patients for whom PAP therapy would be considered effective, but follow-up testing indicated potentially significant residual disease.</p><p><strong>Methods: </strong>As part of standard clinical care, patients in our telemedicine sleep program undergo longitudinal home sleep testing using CPC through the SleepImage system. We retrospectively analyzed remote physiological monitoring data from ResMed PAP devices and CPC-based sleep testing on nights with concomitant data.</p><p><strong>Results: </strong>A total of 465 patients met the inclusion criteria, contributing 24 939 nights of matched PAP and CPC data. Mean AHIFLOW was 2.4 events/hour, while mean AHICPC was 12.1 events/hour. Among nights with AHIFLOW < 5 events/hour, 85% of nights had AHICPC ≥ 5 events/hour, 47.7% had AHICPC ≥ 10 events/hour; 28.3% had ≥5 minutes with SpO2 < 90%, and 10.6% had ≥5 minutes with SpO2 < 88%.</p><p><strong>Conclusions: </strong>PAP download reports are useful for assessing usage and leak, but may underestimate residual respiratory burden. Besides periods of non-use, device-based flow-based metrics alone can miss clinically meaningful residual disease, including hypoxic events during REM sleep. Reliance on PAP-derived AHI as the sole efficacy metric risks overlooking persistent disease.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148424320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-11-08DOI: 10.1093/sleep/zsag293
Krzysztof Różanowski, Michał Jankowski
{"title":"Autonomic and Cortical Signatures of Sleepiness After Prolonged Sleep Deprivation: Pupillary Reflex, Hippus Oscillations, and Visual Evoked Potentials.","authors":"Krzysztof Różanowski, Michał Jankowski","doi":"10.1093/sleep/zsag293","DOIUrl":"https://doi.org/10.1093/sleep/zsag293","url":null,"abstract":"<p><strong>Study objectives: </strong>To define physiologically interpretable visual biomarkers of progressive sleepiness during 48-hour total sleep deprivation and determine whether pupillary and cortical visual measures detect changes not captured by brief behavioral or resting cardiovascular assessments.</p><p><strong>Methods: </strong>Twenty-four healthy adults completed one rested baseline assessment and eight supervised deprivation sessions across 48 hours of continuous wakefulness. The protocol included digital pupillometry during the pupillary light reflex (PLR) and Pupillary Sleepiness Test (PST), pattern-reversal and flash visual evoked potentials (VEPs), Stanford Sleepiness Scale (SSS) ratings, selected psychophysiological tasks, and resting blood pressure and heart rate measurements.</p><p><strong>Results: </strong>PLR latency, reaction duration, and time to minimum diameter changed early, indicating slowed reflex timing. With advanced deprivation, DDil1 and DDil2 (pupil diameters at predefined early and late stages of redilation) decreased, identifying them as recovery-phase markers beyond classical PLR indices. The absolute Pupillary Unrest Index (PUI), measuring spontaneous pupillary oscillations (hippus), rose during the first deprivation night and remained elevated; the pupil-size-normalized rPUI followed slightly later, whereas mean pupil diameter was less informative. VEPs added a cortical layer: peak latencies of the pattern-reversal P100 and N135 and flash N3 and P3 components were delayed after prolonged wakefulness. SSS ratings increased progressively, while brief psychophysiological task performance and resting cardiovascular measures remained comparatively stable.</p><p><strong>Conclusions: </strong>Prolonged wakefulness was reflected by a temporally organized visual biomarker profile spanning phasic pupillary reflex timing, dilation-phase recovery, tonic pupillary instability, and late cortical visual-response slowing. These findings support a candidate multimodal, non-invasive framework for objective assessment of progressive sleepiness.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149371407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Poor Test-Retest Stability of Nocturnal REM Sleep Onset Markers in Narcolepsy Type 1.","authors":"Alexandre Derre, Claire Denis, Séverine Beziat, Isabelle Jaussent, Lucie Barateau, Yves Dauvilliers","doi":"10.1093/sleep/zsag292","DOIUrl":"https://doi.org/10.1093/sleep/zsag292","url":null,"abstract":"<p><strong>Study objectives: </strong>To assess the test-retest stability of nocturnal sleep-onset REM periods (nSOREMPs) in untreated patients with narcolepsy type 1 (NT1), and of nocturnal direct REM (nDREM) transitions and their clinical and biological correlates.</p><p><strong>Methods: </strong>We included consecutive children and adults with NT1 diagnosed according to ICSD-3-TR criteria based on excessive daytime sleepiness, cataplexy, multiple sleep latency test (MSLT) findings, or CSF hypocretin-1 deficiency, without using nSOREMPs for diagnosis. All patients underwent two untreated overnight polysomnographic (PSG). nSOREMP was defined as REM sleep within 15 minutes of sleep onset, and nDREM as direct transition from wakefulness or N1 to REM sleep without intervening N2 or N3 sleep.</p><p><strong>Results: </strong>Among 227 patients (108 males; mean age 31.6 years (SD=14.8)), nSOREMPs were present on both PSGs in 41.8%, on one only in 35.7%, and absent on both in 22.4%, yielding poor test-retest agreement (κ=0.26, 95% CI 0.14-0.39, McNemar test p=0.10). Persistent nSOREMPs were associated with younger age, shorter sleep latency, more SOREMPs on the MSLT, and lower hypocretin levels, but not with PSG interval, symptom severity, or medication history. nDREM was present on both PSGs in 15.9%, on one PSG in 37.4%, and absent on both in 46.7%, with poor stability and persistence associated with younger age, shorter MSLT sleep latency, and lower CSF hypocretin levels.</p><p><strong>Conclusions: </strong>nSOREMPs and nDREMs showed limited test-retest stability in untreated children and adults with NT1. Their association with age, MSLT findings, and hypocretin levels suggest variable REM dysregulation rather than stable individual traits. Absence of nSOREMP even on two PSG should not exclude NT1.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cardiac Autonomic Association Atlas of Sleep Parameters in Obstructive Sleep Apnea: A Large-Scale Cohort-Based Observational Study.","authors":"Chenyang Li, Yunqiu Chu, Enhui Zhou, Hangdong Shen, Xinyi Li, Yupu Liu, Weijun Huang, Jian Guan, Jianyin Zou, Xiaoyue Zhu, Huajun Xu, Hongliang Yi, Shankai Yin","doi":"10.1093/sleep/zsag291","DOIUrl":"https://doi.org/10.1093/sleep/zsag291","url":null,"abstract":"<p><strong>Study objectives: </strong>To systematically evaluate associations between multidimensional sleep parameters and non-invasive cardiac autonomic nervous system metrics derived from heart rate variability (HRV) in patients with obstructive sleep apnea, and to identify the autonomic pathways most closely linked to sleep disturbances.</p><p><strong>Methods: </strong>Using overnight polysomnography from the Shanghai Sleep Health Study cohort, a three-stage dimensionality-reduction strategy compressed 147 sleep parameters and 68 HRV metrics into 59 parameters (5 functional domains) and 25 metrics (5 autonomic domains). For each sleep-HRV pair, multivariable linear regression was adjusted for age, sex, BMI, blood pressure, fasting glucose, and lipids. False discovery rate was controlled via the Benjamini-Yekutieli method, with robustness assessed through 2,000 bootstrap resamples and an independent test set.</p><p><strong>Results: </strong>Among 9,359 subjects (training 6,551; test 2,808), 646 of 1,475 associations were significant after correction; 602 (93.2%) showed directional consistency across bootstraps, with 80.3% test-set reproducibility. The Regulatory Complexity and Sympathovagal Balance domains were enriched in Nocturnal Hypoxemia (71.7%, 63.3%) and Fragmentation & Arousal (66.7%, 58.3%), whereas Baroreflex & Ectopic Domain was systematically sparse (6.7% to 20.0%). Core associations arose almost exclusively from Respiratory Event Burden and Nocturnal Hypoxemia, diverging directionally: positive with Lempel-Ziv complexity, skewness, and VLF power, yet negative with Higuchi fractal dimension, normalized corrected conditional entropy.</p><p><strong>Conclusions: </strong>Nocturnal Hypoxemia and Fragmentation & Arousal are preferentially linked to nonlinear dynamics reflecting Regulatory Complexity and Sympathovagal Balance, whereas Baroreflex & Ectopic metrics are only selectively engaged. This atlas provides a unified framework for generating testable hypotheses and selecting clinically meaningful autonomic biomarkers.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-11-02DOI: 10.1093/sleep/zsag286
Yue-Nan Ni, Eline Oppersma, Wolfgang Ganglberger, Robert Joseph Thomas
{"title":"Respiratory self-similarity is a sleep apnea endotype that predicts cardiovascular disease related mortality.","authors":"Yue-Nan Ni, Eline Oppersma, Wolfgang Ganglberger, Robert Joseph Thomas","doi":"10.1093/sleep/zsag286","DOIUrl":"https://doi.org/10.1093/sleep/zsag286","url":null,"abstract":"<p><strong>Study objectives: </strong>Pathological respiratory chemoreflex activation (high loop gain) in sleep apnea may activate the carotid body and induce excessive sympathetic nerve output, and independently add to the risk of adverse outcomes. This study aims to determine whether a high loop gain of the respiratory control system during sleep, estimated by respiratory self-similarity (SS) and the algorithm-derived central respiratory event index (CREI), is associated with new-onset cardiovascular disease (CVD) and CVD-related mortality.</p><p><strong>Methods: </strong>A secondary analysis of The Sleep Heart Health Study (SHHS) and Multi-Ethnic Study of Atherosclerosis (MESA). High SS% and CREI were defined as the highest quartile. Lasso regression and restricted cubic spline assessed the relationship between SS%, CREI and CVD, CVD-mortality and all-cause mortality. A cumulative incidence function and a Fine-Gray subdistribution hazard model were used to evaluate this outcome accounting for competing risks.</p><p><strong>Results: </strong>In adjusted models with age as a categorical variable divided by 65 years old, the highest quartile of SS% (HR 1.693, p: 0.017 in MESA and HR 1.240, p : 0.009 in SHHS) was associated with the incidence of CVD and was more prominent in males. A positive relationship between SS% (MESA: HR 1.429, p: 0.039; SHHS HR1.176, p:0.018 ) for the continuous metrics and CVD mortality in both cohorts was more apparent in men than in women. The categorical high-exposure association with CVD mortality was not consistent across cohorts.The associations were significantly attenuated when adjusted by age as a continuous metric.</p><p><strong>Conclusions: </strong>An endotype of sleep apnea reflecting high loop gain is associated with CVD and CVD mortality, especially in males.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-11-02DOI: 10.1093/sleep/zsag290
Ki-Young Jung
{"title":"Response to \"From spectral parameterization to spectral staging in isolated REM sleep behavior disorder\".","authors":"Ki-Young Jung","doi":"10.1093/sleep/zsag290","DOIUrl":"https://doi.org/10.1093/sleep/zsag290","url":null,"abstract":"","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SleepPub Date : 2026-10-31DOI: 10.1093/sleep/zsag287
Shahrokh Javaheri, Rami N Khayat, William T Abraham, Rui Wang, Susan Redline
{"title":"LOW-FLOW NOCTURNAL OXYGEN THERAPY FOR THE TREATMENT OF CENTRAL SLEEP APNEA IN CHRONIC HEART FAILURE: THE PAST, the PRESENT, and the FUTURE.","authors":"Shahrokh Javaheri, Rami N Khayat, William T Abraham, Rui Wang, Susan Redline","doi":"10.1093/sleep/zsag287","DOIUrl":"https://doi.org/10.1093/sleep/zsag287","url":null,"abstract":"<p><p>Central sleep apnea (CSA), commonly seen in patients with heart failure and reduced ejection fractions (HFrEF), is associated with hypoxia, heightened sympathetic activity, and poor clinical outcomes. While several CSA therapies reduce the apnea-hypopnea index, none have been shown to improve long-term important clinical outcomes. Nocturnal oxygen therapy (NOT) represents a physiologically sound approach to the treatment of CSA. Evidence supports the potential benefits of NOT in such patients, but no proof of its effectiveness on hard outcomes exists. Thus, there has been a longstanding need for a randomized controlled trial of NOT for CSA in HFrEF patients. The ideal trial would establish the rationale for NOT by measuring clinically meaningful outcomes, use rigorous methodologies such as double-blinding and a sham control, and optimize safety by delivering oxygen at doses that ameliorate hypoxemia and avoid hyperoxia. Such a trial (LOFT-HF NCT03745898) was indeed eventually sponsored by the National Institute of Heath and was initiated in 2018-2019. However, the trial was halted during the COVID-19 pandemic due to slow enrollment. Findings were recently published and did not provide a firm conclusion but suggested potential harm in the NOT arm based on a very small number of participants. Meanwhile, the American Academy of Sleep Medicine (AASM) published recently new treatment guidelines for CSA, suggesting use NOT in CSA. In this article, we attempt to reconcile the LOFT-HF trial findings with existing literature and the new AASM CSA management guidelines and discuss future research needs.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}